Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;36(1):1-6.
doi: 10.3109/00952990903490758.

Substance use and survival after treatment for chronic myelogenous leukemia (CML) or myelodysplastic syndrome (MDS)

Affiliations

Substance use and survival after treatment for chronic myelogenous leukemia (CML) or myelodysplastic syndrome (MDS)

Grace Chang et al. Am J Drug Alcohol Abuse. 2010 Jan.

Abstract

Background: Patients' substance use problems are a particularly understudied aspect of psychosocial variables in cancer treatment.

Objectives: The specific hypothesis tested was that lifetime substance use disorders increased the risk of adverse outcome, in the context of other psychosocial and clinical characteristics demonstrated in other studies to have an impact on treatment outcome.

Method: Prospective cohort study of 106 adults with chronic myelogenous leukemia or primary myelodysplastic syndrome. None satisfied criteria for current substance abuse or dependence, but the lifetime rates of substance use disorders in this sample were 28% for alcohol, 12% for cannabis, and 9% for cocaine.

Results: Participants received treatment as directed by their physicians, and were followed until death or the end of the study (median 1.5 years). Twenty-eight died. Multivariate survival analysis identified three predictors of outcome: lifetime cocaine use, associated with a six-fold increased risk of death (p = .04), and two protective variables, baseline hemoglobin (p = .002) and estimated intelligence quotient (IQ) (p = .04).

Conclusion: The results of this study highlight the potential significance of substance use disorders, and lifetime cocaine diagnoses in particular, on treatment outcome for people with chronic myelogenous leukemia or myelodysplastic syndrome. Whereas neither lifetime alcohol nor cannabis use were associated with survival on either the univariate or multivariate models of survival, lifetime cocaine diagnoses were associated with significant six-fold increased risk of death (p = .04).

PubMed Disclaimer

Conflict of interest statement

Declaration of Interest

The authors report no conflicts of interest. They alone are responsible for the content and writing of the article.

Figures

FIG. 1
FIG. 1
Survival by lifetime cocaine abuse or dependence.
FIG. 2
FIG. 2
Survival by IQ.

Similar articles

Cited by

References

    1. Passik SD, Portenoy RK, Ricketts PL. Substance abuse issues in cancer patients. Part 1: Prevalence and diagnosis. Oncology (Williston Park) 1998;12:517–521. - PubMed
    1. Stagno SJ, Busby K, Shapiro A, Kotz MM. Patients at risk: Addressing addiction in patients undergoing hematopoetic SCT. Bone Marrow Transplant. 2008;42:221–226. - PubMed
    1. Glare P, Virik K, Jones M, Hudson M, Eychmuller S, Simes J, Christakis N. A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ. 2003;327:195–201. - PMC - PubMed
    1. Hoodin F, Uberti JP, Lynch TJ, Steele P, Ratanatharathorn V. Do negative or positive emotions differentially impact mortality after adult stem cell transplant? Bone Marrow Transplant. 2006;38:255–264. - PubMed
    1. Polednak AP. Documentation of alcohol use in hospital records of newly diagnosed cancer patients: A population based study. Am J Drug Alcohol Abuse. 2007;33:403–409. - PubMed

Publication types

MeSH terms